share_log
Reuters ·  May 6 08:00
Rhythm Pharmaceuticals Presents Data From Phase 3 Pediatrics Trial at Pediatric Endocrine Society Annual Meeting
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment